Antibody News and Research

RSS

An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

Engineered macrophages invade and engulf tumor cells in mouse models

One reason cancer is so difficult to treat is that it avoids detection by the body. Agents of the immune system are constantly checking the surfaces of cells for chemical signals that say they belong, but cancer cells express the same chemical signals as healthy ones.

19 Jul 2017

Researchers produce 'silk micrococoons' that could store sensitive molecular materials

Microscopic versions of the cocoons spun by silkworms have been manufactured by a team of researchers.

19 Jul 2017

New antibody-based assay differentiates Zika from similar viral infections

A new test is the best-to-date in differentiating Zika virus infections from infections caused by similar viruses.

18 Jul 2017

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

Researchers from the University of Southampton have identified why some people may become resistant to monoclonal antibodies, a common type of immunotherapy used in lymphoma treatment.

17 Jul 2017

Prior dengue fever in people infected by Zika does not lead to worse illness

Individuals who are infected by Zika virus after having dengue fever do not appear to become more severely ill than people with Zika who have never had dengue.

14 Jul 2017

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

Beckman Coulter welcomes FDA announcement for received regulatory clearance to market its ClearLLab reagents for in vitro diagnostic use in the US.

From Beckman Coulter Life Sciences - Flow Cytometry 14 Jul 2017

TUM researchers decipher binding mechanism of antibody to environmental toxin

Summertime is barbecue time. However, when fat reacts with glowing coal, a substance chemists call benzopyrene is created. It is a widespread environmental toxin that can cause cancer in humans.

13 Jul 2017

MPFI researchers reveal new technique to probe function of cerebellar interneurons

The cerebellum is an area of brain at the back of your head involved in movement. Its neuronal circuitry is relatively simple compared to other areas, but scientists still have a lot left to learn regarding its role in motor control and motor learning.

13 Jul 2017

Diabetes-induced changes in oral microbiome promote periodontal bone loss

A new study led by University of Pennsylvania researchers has found that the oral microbiome is affected by diabetes, causing a shift to increase its pathogenicity.

12 Jul 2017

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.

11 Jul 2017

Novel therapy rapidly and effectively reverses effect of oral blood thinner

At least 28 million prescriptions for blood thinners are filled by pharmacists yearly for the irregular heartbeat of atrial fibrillation, deep vein thrombosis, and other indications, according to the Department of Health and Human Services.

11 Jul 2017

Novel therapy decreases incidence of bleeding by 87% in hemophilia A patients with inhibitors

An international team of hematologists including Guy Young, MD, of Children's Hospital Los Angeles, has found that in patients with hemophilia A with inhibitors, a novel therapy called emicizumab, decreases incidence of bleeding episodes by 87%.

10 Jul 2017

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments.

6 Jul 2017

Sialic acid found in animals protects farm children from asthma

It is a known fact that microbes on farms protect children from asthma and allergies. But even non-microbial molecules can have a protective effect: Immunologists from the University of Zurich have shown that a sialic acid found in farm animals is effective against inflammation of lung tissue.

6 Jul 2017

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

A novel, synthetic, DNA-based strategy to provide protection against a broad array of influenza viruses has been developed in preclinical models by scientists at The Wistar Institute, MedImmune (the global biologics research and development arm of AstraZeneca) and Inovio Pharmaceuticals, Inc.

6 Jul 2017

Emory scientists show how same enzyme spurs Alzheimer's and Parkinson's disease

Alzheimer's disease and Parkinson's disease are not the same. They affect different regions of the brain and have distinct genetic and environmental risk factors.

4 Jul 2017

New therapeutic approach offers hope for individuals with debilitating bone cancer

An Australian-led research team has demonstrated a new therapeutic approach that can re-build and strengthen bone, offering hope for individuals with the debilitating bone cancer, multiple myeloma.

29 Jun 2017

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a natural resistance to the drug, according to a small, proof-of-concept study by Duke Cancer Institute researchers.

29 Jun 2017

Wyss Institute researchers develop new capture technology for cancer diagnostics

Cancerous tumors are formidable enemies, recruiting blood vessels to aid their voracious growth, damaging nearby tissues, and deploying numerous strategies to evade the body's defense systems.

28 Jun 2017

Antibody News and Research

Further Reading

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

Engineered macrophages invade and engulf tumor cells in mouse models

Researchers produce 'silk micrococoons' that could store sensitive molecular materials

New antibody-based assay differentiates Zika from similar viral infections

Southampton researchers find new approach to reverse treatment resistance in lymphoma patients

Prior dengue fever in people infected by Zika does not lead to worse illness

ClearLLab reagents to aid the detection of leukemia and lymphoma receive FDA clearance

TUM researchers decipher binding mechanism of antibody to environmental toxin

MPFI researchers reveal new technique to probe function of cerebellar interneurons

Diabetes-induced changes in oral microbiome promote periodontal bone loss

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

Novel therapy rapidly and effectively reverses effect of oral blood thinner

Novel therapy decreases incidence of bleeding by 87% in hemophilia A patients with inhibitors

Novel vaccine approach appears to protect fetus from CMV infection, animal study shows

Sialic acid found in animals protects farm children from asthma

Scientists develop novel DNA-based strategy to protect against broad array of influenza viruses

Emory scientists show how same enzyme spurs Alzheimer's and Parkinson's disease

New therapeutic approach offers hope for individuals with debilitating bone cancer

Adding new antibody to chemotherapy could bolster effects of cancer treatment

Wyss Institute researchers develop new capture technology for cancer diagnostics

eBook: End-to-end solutions for bispecific antibody development eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo